Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, ​the Germany-based startup said on ...
Under the agreement, Lilly will gain access to Seamless Therapeutics’ proprietary technology, which is used to design specially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results